Companies: 10,795·Total market cap: $144.5T
Burning Rock Biotech Limited

Burning Rock Biotech Limited

BNRNASDAQHealthcare● Active
$9.07
$-0.14(-1.52%)
Market Cap$9641782
P/E Ratio—
52W High$41.72
52W Low$2.95
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Burning Rock Biotech Limited (BNR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001792267 · BNR · NASDAQ · as of Jun 9, 2026

Filing snapshot

166
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-15
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001792267 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-28
Fiscal Year End
Apr 28, 2026
Accession No.
0001193125-26-183377
Primary Document
d31568d20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001792267 · Accession 0001193125-26-183377

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-03-13
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-13
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2026-04-28
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-17
View
3Initial Statement of Beneficial Ownership
3
2026-03-17
View
3Initial Statement of Beneficial Ownership
3
2026-03-17
View
3Initial Statement of Beneficial Ownership
3
2026-03-17
View
3Initial Statement of Beneficial Ownership
3
2026-03-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-12-23
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-12-19
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-12-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-11-20
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-14
View
Showing 1–15 of 165 filingsForm 4 / 144 hidden· 166 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001792267  |  Exchange: NASDAQ · Healthcare

Burning Rock Biotech Limited (NASDAQ: BNR) has submitted 166 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001792267, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Burning Rock Biotech Limited's most comprehensive regulatory disclosure. The most recent Burning Rock Biotech Limited 10-K was filed on 2026-04-28 for fiscal year ending 2026. Historical BNR 10-K annual reports are available from 2019 through 2026.

Investors researching Burning Rock Biotech Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
EKSO SEC Filings →AYTU SEC Filings →PMN SEC Filings →AMS SEC Filings →CODX SEC Filings →ALUR SEC Filings →ADVB SEC Filings →AEMD SEC Filings →
→ BNR Financials→ BNR Earnings→ BNR Insider Trades

Frequently Asked Questions

BNR SEC Filings · 8 questions

Burning Rock Biotech Limited (BNR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 166 filings and access original documents at no cost. Burning Rock Biotech Limited's CIK is 0001792267.

BNR SEC filingsBurning Rock Biotech Limited SEC documentsfind BNR 10-K